StandardAero (SARO) Q3 2026 Earnings Call Transcript

StandardAero reported Q3 revenue of $1.557 billion, up 4% year over year, while adjusted EBITDA rose 15% to $224.9 million and adjusted diluted EPS increased 30% to $0.39; adjusted EBITDA margin expanded 130 basis points to 14.4%. The company raised 2026 revenue guidance to $6.525–$6.645 billion and adjusted EBITDA guidance to $905–$920 million, and announced a $350 million accelerated share repurchase as part of an approximately $1.01 billion authorization. Component Repair Services faced unfavorable mix and delays in select military programs, while management said demand visibility extends into 2028.

Analysis

The earnings quality is improving, but the quarter’s margin acceleration is not yet a clean run-rate signal: it combines productivity and learning-curve gains with pass-through mix effects and unusually favorable, explicitly opportunistic USM sourcing. Management’s own Q4 commentary points to both a reversal of that USM benefit and dilution from ramping LEAP/CFM56 work. The key test is whether Engine Services can hold margin expansion as those programs scale without another favorable sourcing quarter.

The more important 6–18 month upside is operating leverage from throughput, repair capture, and the new CEO’s focus on Component Repair Services—not simply the headline LEAP revenue ambition. If internal repair capability lowers material cost and turnaround time, it can strengthen StandardAero’s customer proposition and reduce exposure to constrained external parts supply. But CRS currently has execution and timing risk: commercial demand is healthy while military training-related work is delayed, and the return depends partly on operating tempo and program outlays.

The $350 million ASR supports per-share results but competes with investment and M&A for capital while leverage remains within, rather than below, the company’s stated target range. Near term, guidance and backlog visibility are supportive; the contrarian risk is that investors capitalize episodic USM and buybacks as structural earnings growth. Verify cash conversion and segment margins before underwriting the multiple. A slowdown in inductions, weaker bookings, persistent military delays, or failure to convert backlog into cash would challenge the thesis.

Key Decisions for Investors

• SARO: Favor a staged long only on weakness or after confirmation in the next results, rather than chasing the guidance raise. Require Engine Services margins to remain resilient as USM benefits normalize and LEAP/CFM56 volumes rise; no valuation or current-price data were supplied to support a price target.
• Over the next 1–3 months, monitor Q4 adjusted free cash flow against the $270–$300 million full-year range, receivables/contract-asset unwind, and CRS military activity. A miss in cash conversion or another CRS margin setback would weaken the near-term case even if revenue holds.
• Treat LEAP as a 6–18 month execution catalyst, not a near-term earnings guarantee. Track shop-visit throughput, repair-content capture, and profitability as volumes scale; delayed material inputs or deteriorating turnaround times would falsify the operating-leverage thesis.
• Do not treat the ASR as unambiguously bullish: assess net leverage and remaining capacity for organic investment or acquisitions after completion. Reconsider the long thesis if leverage trends above the stated 2–3x range or buybacks appear to displace returns-positive capacity and repair investment.